关于其临床使用的Danaparoid-Consensus建议
Rupert M Bauersachs1,2, Edelgard Lindhoff-Last1, Robert Klamroth3
1Cardioangiology Center Bethanien, Vascular Center and Coagulation Center, Im Prüfling 23, 60389 Frankfurt, Germany.
Pharmaceuticals (Basel, Switzerland)
|January 8, 2025
概括
达纳帕洛伊德是一种抗血栓剂,可安全有效地用于DVT预防和治疗氨酸诱导的血栓缩 (HIT). 本综述为复杂的临床情景提供了专家支持的剂量建议.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血栓形成的管理
- 抗凝疗法是一种抗凝疗法.
背景情况:
- 达纳帕洛伊德是一种长期存在的肝类抗血栓剂.
- 它用于非肝素诱导的血小板缺血 (HIT) 患者的深静脉血栓症 (DVT) 预防.
- 它还可以作为HIT的治疗,有或没有血栓形成.
研究的目的:
- 更新关于达纳帕洛伊德的药理信息.
- 审查跨不同临床情况的达纳帕洛伊德剂量管理,包括非标签用途.
- 建立对复杂病例和脆弱人群的剂量方案的共识.
主要方法:
- 分析已发表的临床研究和病例报告.
- 包括来自同情使用和不良事件报告的数据.
- 由一个跨学科专家小组制定共识.
主要成果:
- 达纳帕洛伊德的建议剂量方案.
- 关于监测抗凝血的建议.
- 确定有效治疗的目标抗Xa因子范围.
结论:
- 提供了全面的跨学科剂量建议.
- 这些指导方针旨在确保安全有效地使用达纳帕洛伊德.
- 这些建议为在复杂的患者群体中管理抗凝血剂提供了基础.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
146
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
146
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


